Basecamp Vascular specialises in the research and development of medical devices, particularly in the fields of surgical robotics, endovascular treatment, interventional neurology and interventional oncology.

With this new round of financing, the company welcomes Forepont Capital Partners, New York-based international venture capital firm that invests in biotech start-ups and disruptive medical technologies, NeuroTechnology Investors, made up of doctors from around the world specialising in neurosurgery, neurology and several vascular specialities (United States), MedCo (France) and several French investors.

The arrival of these new investors represents a new stage in the startup's development and geographical expansion.

The Reed Smith team working alongside Basecamp Vascular included partner Marc Fredj, and corporate lawyers Antea Bonito and Alex Ebangue.